PharmaVOICE - 
February 2010
Purchase Issue

In Every Issue
Last Word
Rewarding Performance Procter & Gamble is a recognized leader in [...]
By
Talent Pool
Biotechnology POOL Dr. Paul LAMMERS Mirna Appoints Chief Executive Mirna [...]
By
E-media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: [...]
By
What’s New
New Healthcare-related Products, Services, and Companies Featured Briefs: Pharma Industry [...]
By
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: [...]
By
Upfront
Honors and Awards G&A Receives ­Recognition The Rx Club presented [...]
By
Letter from the Editor
In our lifetime… There are few, if any, of us [...]
By

Taren Grom, Editor

On The Cover

Opportunities in Oncology Development
Advances in cancer research, knowledge, treatment options, and awareness have increased tremendously in the past 25 years. Rates of new diagnoses and deaths from all cancers have declined significantly for men and women overall and for most racial and ethnic populations in the United States, according to the National Cancer Institute. These decreases are driven [...]
By

Denise Myshko

Features

The New Washington Office
The legislative push for healthcare reform came with a speed and scope that surprised many in the pharmaceutical industry, drawing new attention to the Washington, D.C., offices of many drug companies. With this new attention comes the potential for new roles and responsibilities for Washington-based pharmaceutical company staff and an opportunity to have a significant [...]
By

Dennis R. Cryer, M.D., FAHA and Donna R. Cryer, J.D., CryerHealth

Reducing Regulatory Risk for the Development of Drugs, Biologics, and Devices
Thorough review of all FDA activity in the area of clinical development provides insights into regulatory risks. This information can be used to: n Evaluate and review clinical investigators and CROs. n Develop effective strategies for managing clinical initiatives. n Establish improved monitoring programs. n Ensure proper investigational review board (IRB) involvement and review. n [...]
By

Michael Kuehne, ACSYS Inc.

Help Wanted: Pharma Bloggers
Social media specialist positions are growing exponentially — just Google the term to view the jobs that pop up. Many colleges and universities are now offering degrees in how to write, publish, and strategize in this new media field. Hospitals, clinics, and other healthcare organizations have enlisted staff to blog and tweet about programs and [...]
By

Robin Robinson

A 360-Degree View of E-Patient Connections
Healthcare information technology has created the platform for the exchange, collection, and documentation of health data and information, but it is up to the crucial players — patients, physicians, pharma companies, and service providers — to make e-connections work. The patient, the physician, and the industry all have crucial roles in building relationships with each [...]
By

Robin Robinson

FEEDBACK